Pyxis Oncology, Inc. (PYXS)
3.52
-0.37
(-9.51%)
USD |
NASDAQ |
Sep 09, 14:39
Pyxis Oncology Price : 3.52 for Sept. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 4.00 | 4.15 | 3.845 | 3.89 | 1.376M |
| Sep 04, 2026 | 3.53 | 4.05 | 3.515 | 3.89 | 2.231M |
| Sep 03, 2026 | 3.71 | 3.74 | 3.45 | 3.565 | 812185.0 |
| Sep 02, 2026 | 3.45 | 3.77 | 3.435 | 3.75 | 731710.0 |
| Sep 01, 2026 | 3.24 | 3.57 | 3.18 | 3.44 | 590695.0 |
| Aug 31, 2026 | 3.20 | 3.28 | 3.050 | 3.24 | 469508.0 |
| Aug 28, 2026 | 3.32 | 3.380 | 3.20 | 3.23 | 211992.0 |
| Aug 27, 2026 | 3.31 | 3.37 | 3.23 | 3.32 | 396776.0 |
| Aug 26, 2026 | 3.03 | 3.36 | 3.00 | 3.34 | 634702.0 |
| Aug 25, 2026 | 2.96 | 3.09 | 2.94 | 3.06 | 422222.0 |
| Aug 24, 2026 | 3.02 | 3.07 | 2.825 | 2.96 | 837591.0 |
| Aug 21, 2026 | 3.15 | 3.21 | 3.02 | 3.08 | 682275.0 |
| Aug 20, 2026 | 3.30 | 3.39 | 3.03 | 3.12 | 716268.0 |
| Aug 19, 2026 | 3.07 | 3.50 | 3.06 | 3.37 | 1.036M |
| Aug 18, 2026 | 3.03 | 3.13 | 2.97 | 2.99 | 353484.0 |
| Aug 17, 2026 | 3.03 | 3.09 | 2.83 | 3.02 | 558935.0 |
| Aug 14, 2026 | 2.99 | 3.08 | 2.862 | 3.01 | 703831.0 |
| Aug 13, 2026 | 2.95 | 3.35 | 2.75 | 3.01 | 1.267M |
| Aug 12, 2026 | 2.76 | 3.211 | 2.72 | 3.18 | 1.936M |
| Aug 11, 2026 | 3.85 | 4.00 | 1.90 | 2.83 | 12.12M |
| Aug 10, 2026 | 3.72 | 3.985 | 3.72 | 3.83 | 999096.0 |
| Aug 07, 2026 | 3.78 | 3.90 | 3.62 | 3.73 | 1.242M |
| Aug 06, 2026 | 3.14 | 3.77 | 3.13 | 3.75 | 1.396M |
| Aug 05, 2026 | 3.20 | 3.318 | 3.07 | 3.13 | 668798.0 |
| Aug 04, 2026 | 3.02 | 3.25 | 3.02 | 3.16 | 926187.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.85 |
| Alnylam Pharmaceuticals, Inc. | 254.27 |
| Anika Therapeutics, Inc. | 21.00 |
| Savara, Inc. | 5.405 |
| Vericel Corp. | 39.07 |
Price Related Metrics
| PS Ratio | 20.15 |
| Price to Book Value | 19.52 |
| Earnings Yield | -39.87% |
| Market Cap | 223.29M |